|
|
@@ -63,6 +63,7 @@
|
|
|
)
|
|
|
],
|
|
|
)
|
|
|
+
|
|
|
#simple_dia(
|
|
|
[👨⚕️ Model --- T-ALL ],
|
|
|
[
|
|
|
@@ -147,7 +148,7 @@
|
|
|
[
|
|
|
#set align(center + horizon)
|
|
|
#v(10pt)
|
|
|
- Cases *refractory* to chemotherapy as well as *relapses* (UKALL12: adults at 5
|
|
|
+ *Refractory* cases to standard chemotherapy as well as *relapses* (UKALL12: adults at 5
|
|
|
years 42%) have a poor prognosis.
|
|
|
#v(10pt)
|
|
|
],
|
|
|
@@ -180,8 +181,7 @@
|
|
|
[
|
|
|
#set align(center + horizon)
|
|
|
#v(10pt)
|
|
|
- We also believe that the tumor phenotype results from modifications in the
|
|
|
- genotype.
|
|
|
+ The tumor phenotype emerges from alterations in their genotype.
|
|
|
|
|
|
#sym.arrow.r.stroked A better description of the genotype will lead to a better
|
|
|
understanding of oncogenic mechanisms and to the discovery of more *effective
|
|
|
@@ -203,7 +203,9 @@
|
|
|
auto,
|
|
|
auto,
|
|
|
[
|
|
|
- *Somatic intergenic alterations are responsible for the deregulation of
|
|
|
+ #set align(center + horizon)
|
|
|
+
|
|
|
+ *Somatic intergenic alterations are responsible of the deregulation of
|
|
|
oncogenes.*
|
|
|
#image("./Images/bradner_cis_small.png")
|
|
|
],
|
|
|
@@ -220,8 +222,8 @@
|
|
|
auto,
|
|
|
auto,
|
|
|
[
|
|
|
- - Our laboratory has shown that an insertion upstream of _TAL1_ leads to the
|
|
|
- formation of a *neo-enhancer* and thus the overexpression of _TAL1_.
|
|
|
+ - Our laboratory has shown that a somatic insertion upstream of _TAL1_ leads to the
|
|
|
+ formation of a *neo-enhancer* and thus leads to the overexpression of _TAL1_.
|
|
|
#set align(center)
|
|
|
#image("./Images/tal_ins.png", height: 66%)
|
|
|
],
|
|
|
@@ -240,17 +242,25 @@
|
|
|
auto,
|
|
|
auto,
|
|
|
[
|
|
|
- - Implement a method for sequencing the *whole tumoral genome*.
|
|
|
- - Detect structural variations (SV) and SNV with good sensitivity/specificity.
|
|
|
- - Describe a set of somatic intergenic alterations likely responsible for the
|
|
|
- deregulation of known oncogenes.
|
|
|
- - Identify similar alterations deregulating genes not known to be oncogenes.
|
|
|
- ],
|
|
|
+ - *Implement* a method for sequencing the *whole tumoral genome*.
|
|
|
+ #uncover(
|
|
|
+ (2, 3, 4, 5),
|
|
|
+ [- *Detect* structural variations (SV) and SNV with good sensitivity/specificity.],
|
|
|
+ )
|
|
|
+ #uncover(
|
|
|
+ (3, 4, 5),
|
|
|
+ [- *Describe* a set of somatic intergenic alterations likely responsible for the deregulation of known oncogenes.],
|
|
|
+ )
|
|
|
+ #uncover(
|
|
|
+ (4, 5),
|
|
|
+ [- *Discover* similar alterations deregulating genes not known to be oncogenes.
|
|
|
+ ],
|
|
|
+ )],
|
|
|
[],
|
|
|
)
|
|
|
|
|
|
#uncover(
|
|
|
- 2,
|
|
|
+ 5,
|
|
|
[
|
|
|
#double_boxes(
|
|
|
auto,
|
|
|
@@ -258,7 +268,7 @@
|
|
|
[
|
|
|
#set align(center)
|
|
|
*#sym.arrow.r.stroked* Implementation of the *Oxford Nanopore sequencing
|
|
|
- method*.
|
|
|
+ method* and integrate multi-omics data.
|
|
|
],
|
|
|
[],
|
|
|
)
|
|
|
@@ -386,8 +396,8 @@
|
|
|
[
|
|
|
1. *Base calling* and *Alignement* on hs1 (T2T).
|
|
|
|
|
|
- Latest version of Dorado 0.6.0 with latest AI model of 5mC 5hmC modified
|
|
|
- basecalling (v4.3).
|
|
|
+ Latest version of Dorado 0.8.1 with latest AI model of 5mC 5hmC modified
|
|
|
+ basecalling (v5.0).
|
|
|
|
|
|
#set align(center + horizon)
|
|
|
#grid(
|
|
|
@@ -466,13 +476,14 @@
|
|
|
auto,
|
|
|
[
|
|
|
3. Annotations
|
|
|
- - VEP for variant consequence prediction (ensembl v110.1)
|
|
|
- - Cosmic (latest)
|
|
|
+ - VEP for variant consequence prediction (ensembl v112)
|
|
|
+ - Cosmic DB (latest)
|
|
|
+ - dbSNP
|
|
|
- NCBI genomic regions (latest)
|
|
|
],
|
|
|
[],
|
|
|
)
|
|
|
- #image("./Images/vep_consequences.svg", height: 65%)
|
|
|
+ #image("./Images/vep_consequences.svg", height: 60%)
|
|
|
],
|
|
|
)
|
|
|
|
|
|
@@ -519,10 +530,10 @@
|
|
|
auto,
|
|
|
[
|
|
|
Implementation of _de novo assemblage_ for LRS: \
|
|
|
- Inspired by *SV-finder* (local de novo assemblage)
|
|
|
+ Inspired by *SV-finder* (local de novo assembly)
|
|
|
- *Scan* alignements and select locally misaligned reads (outliers detection).
|
|
|
- *Assemble* them together (wtdbg2 v2.5 and spades v4.0).
|
|
|
- - *Describe* the consensus sequence (Blast, minimap2).
|
|
|
+ - *Describe* the resulting consensus sequence (Blast, minimap2).
|
|
|
],
|
|
|
[],
|
|
|
)
|
|
|
@@ -569,33 +580,39 @@
|
|
|
80%,
|
|
|
[
|
|
|
#set align(center + horizon)
|
|
|
- After the interpretation of the results and the redaction of a conclusion.
|
|
|
+ After the manual interpretation of the results and the redaction of a conclusion.
|
|
|
],
|
|
|
[],
|
|
|
)
|
|
|
|
|
|
- #double_boxes(
|
|
|
- auto,
|
|
|
- 80%,
|
|
|
- [
|
|
|
- #set align(left)
|
|
|
- The system generates a detailed PDF report that seamlessly integrates:
|
|
|
+ #uncover(
|
|
|
+ (2, 3),
|
|
|
+ double_boxes(
|
|
|
+ auto,
|
|
|
+ 80%,
|
|
|
+ [
|
|
|
+ #set align(left)
|
|
|
+ The system generates a detailed PDF report that seamlessly integrates:
|
|
|
|
|
|
- + Detailed quality metrics (with graphics generation)
|
|
|
- + Interpreted genetic mutations (Pathogenic, ...)
|
|
|
- + Analytical conclusions
|
|
|
- ],
|
|
|
- [],
|
|
|
+ + Detailed quality metrics (with graphics generation)
|
|
|
+ + Interpreted genetic mutations (Pathogenic, ...)
|
|
|
+ + Analytical conclusions
|
|
|
+ ],
|
|
|
+ [],
|
|
|
+ ),
|
|
|
)
|
|
|
|
|
|
- #double_boxes(
|
|
|
- auto,
|
|
|
- 25%,
|
|
|
- align(
|
|
|
- center,
|
|
|
- link("http://localhost/data/longreads_basic_pipe/CHAMPION/diag/report/CHAMPION_report.pdf")[Example...],
|
|
|
+ #uncover(
|
|
|
+ 3,
|
|
|
+ double_boxes(
|
|
|
+ auto,
|
|
|
+ 25%,
|
|
|
+ align(
|
|
|
+ center,
|
|
|
+ link("http://localhost/data/longreads_basic_pipe/CHAMPION/diag/report/CHAMPION_report.pdf")[Example...],
|
|
|
+ ),
|
|
|
+ [],
|
|
|
),
|
|
|
- [],
|
|
|
)
|
|
|
],
|
|
|
)
|
|
|
@@ -612,9 +629,9 @@
|
|
|
[
|
|
|
Initially, to investigate our hypothesis, we decided to sequence T-ALLs
|
|
|
harboring deregulation of the expression of known frequent oncogenes in T-ALL:
|
|
|
- - * _TAL1_ *,
|
|
|
- - * _HOXA9_ * and
|
|
|
- - * _TLX1_* deregulated without genetic explanation.
|
|
|
+ - *_TAL1_* (cis-deregulated),
|
|
|
+ - *_HOXA9_* (RT-MLPA neg),
|
|
|
+ - * _TLX1_* deregulated without genetic explanation (FISH neg and NGS panel neg).
|
|
|
],
|
|
|
[],
|
|
|
)
|
|
|
@@ -957,7 +974,13 @@
|
|
|
[🧬 Interesting results: TAL1],
|
|
|
align(
|
|
|
center + horizon,
|
|
|
- double_boxes(auto, 60%, align(center)[show CAMA MYB insertion on line…], []),
|
|
|
+ double_boxes(
|
|
|
+ auto,
|
|
|
+ 60%,
|
|
|
+ align(center)[🌐 show CAMA MYB insertion on line…],
|
|
|
+
|
|
|
+ [],
|
|
|
+ ),
|
|
|
),
|
|
|
)
|
|
|
|
|
|
@@ -977,18 +1000,24 @@
|
|
|
#v(12pt)
|
|
|
|
|
|
- Surexpression of TLX1.
|
|
|
- - Inv10
|
|
|
- - Modification of 3' UTR.
|
|
|
+ #uncover((2, 3), [- Inv10 ])
|
|
|
+ #uncover(3, [- Modification of 3' UTR.])
|
|
|
],
|
|
|
[],
|
|
|
)
|
|
|
- #double_boxes(auto, auto, image("./Images/utr_tlx1.png"), [])
|
|
|
+ #uncover(
|
|
|
+ 3,
|
|
|
+ double_boxes(auto, auto, image("./Images/utr_tlx1.png"), []),
|
|
|
+ )
|
|
|
],
|
|
|
- double_boxes(
|
|
|
- auto,
|
|
|
- auto,
|
|
|
- image("./Images/LEV_inv10_tlx1.png", height: 75%),
|
|
|
- [],
|
|
|
+ uncover(
|
|
|
+ (2, 3),
|
|
|
+ double_boxes(
|
|
|
+ auto,
|
|
|
+ auto,
|
|
|
+ image("./Images/LEV_inv10_tlx1.png", height: 75%),
|
|
|
+ [],
|
|
|
+ ),
|
|
|
),
|
|
|
),
|
|
|
)
|